Valuation: Astellas Pharma Inc.

Market Cap 3,848B 23.74B 20.75B 19.15B 17.6B 33.35B 2,284B 33.92B 229B 89.69B 1,116B 89.15B 87.2B P/E 2027 *
11.2x
P/E 2028 * 11.7x
Enterprise Value 3,704B 22.85B 19.98B 18.43B 16.94B 32.1B 2,199B 32.65B 220B 86.33B 1,075B 85.82B 83.93B EV / Sales 2027 *
1.64x
EV / Sales 2028 * 1.63x
Free-Float
97.66%
Yield 2027 *
3.75%
Yield 2028 * 3.86%
1 day+0.28%
1 week+0.07%
Current month-1.24%
1 month-0.21%
3 months-17.56%
6 months-6.69%
Current year+2.63%
1 week 2,109
Extreme 2109
2,176
1 month 2,105
Extreme 2105
2,216.5
Current year 2,041
Extreme 2041
2,717
1 year 1,422.5
Extreme 1422.5
2,717
3 years 1,243.5
Extreme 1243.5
2,717
5 years 1,243.5
Extreme 1243.5
2,717
10 years 1,243.5
Extreme 1243.5
2,717
Manager TitleAgeSince
Chief Executive Officer 63 09/02/2023
Director of Finance/CFO 54 31/10/2023
Compliance Officer - 31/03/2025
Director TitleAgeSince
Chairman 66 09/02/2023
Director/Board Member 63 31/05/2019
Director/Board Member 58 31/05/2023
Change 5-day change 1-year change 3-year change Capi.($)
+0.28%+0.07%+48.96%+7.13% 23.67B
+2.09%-3.04%+49.40%+163.90% 1,031B
+0.88%-3.95%+51.02%+56.44% 595B
+2.78%+0.39%+31.64%+86.07% 431B
+0.42%-1.16%+29.43%+23.64% 326B
+1.03%-0.84%+29.58%+45.15% 277B
+0.49%-5.44%+21.00%+23.80% 263B
+1.59%+4.89%-22.56%-37.35% 224B
+2.57%+1.36%+23.26%+61.77% 193B
+0.88%-1.23%+21.24%+71.89% 164B
Average +1.24%-3.43%+28.30%+50.24% 352.8B
Weighted average by Cap. +1.47%-4.28%+34.68%+79.85%

Financials

2027 *2028 *
Net sales 2,258B 13.93B 12.18B 11.23B 10.33B 19.57B 1,340B 19.9B 134B 52.62B 655B 52.31B 51.16B 2,074B 12.8B 11.19B 10.32B 9.49B 17.98B 1,231B 18.28B 123B 48.34B 602B 48.05B 47B
Net income 344B 2.12B 1.86B 1.71B 1.57B 2.98B 204B 3.03B 20.43B 8.02B 99.79B 7.97B 7.79B 327B 2.02B 1.77B 1.63B 1.5B 2.84B 194B 2.89B 19.45B 7.63B 95B 7.59B 7.42B
Net Debt -144B -888M -776M -716M -658M -1.25B -85.41B -1.27B -8.55B -3.35B -41.75B -3.33B -3.26B -458B -2.82B -2.47B -2.28B -2.09B -3.97B -272B -4.04B -27.2B -10.67B -133B -10.61B -10.38B
Logo Astellas Pharma Inc.
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Employees
14,099
Date Price Change Volume
16/07/26 JP¥2,148.00 +0.28% 7,147,600
15/07/26 JP¥2,142.00 -0.19% 6,310,600
14/07/26 JP¥2,146.00 +1.18% 5,802,100
13/07/26 JP¥2,121.00 -0.98% 4,304,400
10/07/26 JP¥2,142.00 +0.21% 5,971,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
2,148.00JPY
Average target price
2,384.62JPY
Spread / Average Target
+11.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4503 Stock